产品名称 AT 7519 mesylate
产品货号 Axon 1539 CAS [902135-89-1] MF C16H17Cl2N5O2.CH4O3SMW 478.35 Purity: 99% Soluble in water Description A small molecule inhibitor of multi-CDK, which inhibits CDK 1, 2 , 4, 5, 6, and 9 in vitro and induces apoptosis in multiple myeloma via GSK-3β activation and RNA polymerase II inhibition References Certificates Categories Extra info L Sato et al. AT7519, A novel small molecule multi-cyclin-dependent kinase inhibitor, induces apoptosis in multiple myeloma via GSK-3β activation and RNA polymerase II inhibition. Oncogene 2010, 29, 2325-2336.    MS Squires et al. AT7519, a cyclin-dependent kinase inhibitor, exerts its effects by transcriptional inhibition in leukemia cell lines and patient samples. Mol. Cancer Ther. 2010, 9(4), 920-928.  Certificate of Analysis Material Safety Data Sheet Apoptosis Cell Cycle Regulation Cell Signaling & Oncology p53-Tumor Suppression EC 2.7.11.22 CDK CDK inhibitor Chemical name 4-(2,6-Dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide methanesulfonic acid Parent CAS No. [844442-38-2] Order Size Unit Price Stock 10 mg €80.00 In Stock
产品价格 现货询价,电话:010-67529703
产品规格
产品品牌 axonmedchem
产品概述
产品详情

AT 7519 mesylate

Based on 16 reference(s) in Google Scholar 9 10 16

Axon 1539

CAS [902135-89-1]

MF C16H17Cl2N5O2.CH4O3S
MW 478.35

  • Purity: 99%
  • Soluble in water

AT 7519 mesylate

Description

A small molecule inhibitor of multi-CDK, which inhibits CDK 1, 2 , 4, 5, 6, and 9 in vitro and induces apoptosis in multiple myeloma via GSK-3β activation and RNA polymerase II inhibition
产品资料